Venture Beat -
5 Aug 2017 19:25
GUEST: We’re seeing a new wave of venture investments in healthtech companies — especially those with strong artifical intelligence and machine learning components. Led by some of the world's largest biopharma companies and tech-focused venture capitalists, these investments are backing efforts to speed drug discovery, improve tests and treatments, and further medical research. For now, most […]
Share this Article
Comment on this Article
Please to comment